These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 658129)

  • 1. Inhibition by d,l-methadone of RNA and protein synthesis in neonatal mice: antagonism by naloxone or naltrexone.
    Hui FW; Krikun E; Smith AA
    Eur J Pharmacol; 1978 May; 49(1):87-93. PubMed ID: 658129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth in young mice treated with pentazocine: reversal by naltrexone.
    Wassef NM; Smith AA
    Eur J Pharmacol; 1980 Aug; 66(2-3):155-60. PubMed ID: 6254782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth in young mice treated with d,1-methadone.
    Smith AA; Hui FW; Crofford MJ
    Eur J Pharmacol; 1977 Jun; 43(4):307-14. PubMed ID: 880978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nucleic acid synthesis in the regenerating limb of salamanders treated with a DL-methadone or narcotic antagonists.
    Hui FW; Krikun E; Hirsh EM; Blaiklock RG; Smith AA
    Exp Neurol; 1976 Oct; 53(1):267-73. PubMed ID: 964342
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists.
    Hartmann RJ; Geller I
    Proc West Pharmacol Soc; 1976; 19():243-7. PubMed ID: 11501
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
    Ho AK; Chen RC
    Ann N Y Acad Sci; 1976; 281():297-310. PubMed ID: 1071365
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuronal inhibitory effects of methadone are predominantly opioid receptor mediated in the rat spinal cord in vivo.
    Carpenter KJ; Chapman V; Dickenson AH
    Eur J Pain; 2000; 4(1):19-26. PubMed ID: 10833552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the specific lethal effects of narcotic analgesics in the mouse.
    Shannon HE; Holtzman SG
    Eur J Pharmacol; 1976 Oct; 39(2):295-303. PubMed ID: 976325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone.
    Freye E; Hartung E; Kaliebe S
    Br J Anaesth; 1983 Jan; 55(1):71-7. PubMed ID: 6129881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of narcotic and narcotic antagonist interactions in primates.
    Killam KF; Brocco MJ; Robinson CA
    Ann N Y Acad Sci; 1976; 281():331-5. PubMed ID: 828467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative inhibition of biosynthetic processes in rat liver testicular cells by D-, L,-and DL-methadone.
    Jakubovic A; McGeer EG; McGeer PL
    Biochem Pharmacol; 1978 Jan; 27(1):123-5. PubMed ID: 619897
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth retardation in young mice treated with d1-methadone.
    Crofford M; Smith AA
    Science; 1973 Sep; 181(4103):947-9. PubMed ID: 4730446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent alterations of central opiate systems as a result of chronic opiate antagonism during infancy in rats.
    Diaz J; Paul L; Frenk H; Bailey B
    Proc West Pharmacol Soc; 1978; 21():377-9. PubMed ID: 211530
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonism of morphine-induced respiratory depression with nalmefene.
    Konieczko KM; Jones JG; Barrowcliffe MP; Jordan C; Altman DG
    Br J Anaesth; 1988 Sep; 61(3):318-23. PubMed ID: 3140862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat.
    Ragavan VV; Wardlaw SL; Kreek MJ; Frantz AG
    Neuroendocrinology; 1983 Oct; 37(4):266-8. PubMed ID: 6314167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular aspects of pharmacological activity of naltrexone and naloxone].
    Golovko AI; Golovko SI; Leont'eva LV; Romanenko OI; Konoplin DA
    Eksp Klin Farmakol; 2003; 66(1):71-8. PubMed ID: 12683088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.